Evidence map›Paper›PMID 34929672›Full record

ArticleThe American journal of tropical medicine and hygiene2021

Incidence Estimates of Acute Q Fever and Spotted Fever Group Rickettsioses, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014.

Sruti Pisharody, Matthew P Rubach, Manuela Carugati, William L Nicholson, Jamie L Perniciaro, Holly M Biggs, Michael J Maze, Julian T Hertz, Jo E B Halliday, Kathryn J Allan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 22 citations in OpenAlex.

  1. Systematic review ofOne health (Amsterdam, Netherlands) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. PathogenicJournal of bacteriology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Sruti PisharodyDivision of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.
Matthew P RubachDivision of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.
Manuela CarugatiDivision of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.
William L NicholsonCenters for Disease Control and Prevention, Rickettsial Zoonoses Branch, Atlanta, Georgia.
Jamie L PerniciaroCenters for Disease Control and Prevention, Rickettsial Zoonoses Branch, Atlanta, Georgia.
Holly M BiggsDivision of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.
Michael J MazeKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Julian T HertzDuke Global Health Institute, Duke University, Durham, North Carolina.
Jo E B HallidayInstitute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Kathryn J AllanInstitute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Blandina T MmbagaKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Wilbrod SagandaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Bingileki F LwezaulaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Rudovick R KazwalaSokoine University of Agriculture, Morogoro, Tanzania.
Sarah CleavelandInstitute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.
John A CrumpDivision of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.
Kilimanjaro Christian Medical Centre · TZDuke University Health System · USCenters for Disease Control and Prevention · USGlasgow Centre for Population Health · GBMinistry of Health, Community Development, Gender, Elderly and Children · TZDuke University · USSokoine University of Agriculture · TZUniversity of Glasgow · GB

Funding

Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Viral Zoonoses and Severe Febrile Illness in Northern TanzaniaK23AI116869 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$896k
Biotechnology and Biological Sciences Research Council BB/J010367/1Biotechnology and Biological Sciences Research Council BB/L017679Biotechnology and Biological Sciences Research Council BB/L018845Biotechnology and Biological Sciences Research Council BB/L018845/1Biotechnology and Biological Sciences Research Council BB/L018926Biotechnology and Biological Sciences Research Council BB/L018926/1Biotechnology and Biological Sciences Research Council BB/S013857/1FIC NIH HHS R01 TW009237FIC NIH HHS R25 TW009337NIAID NIH HHS K23 AI116869NIAID NIH HHS R01 AI121378NIAID NIH HHS U01 AI062563Wellcome Trust 096400/Z/11/Z
6 · The paper itself

Abstract

Q fever and spotted fever group rickettsioses (SFGR) are common causes of severe febrile illness in northern Tanzania. Incidence estimates are needed to characterize the disease burden. Using hybrid surveillance-coupling case-finding at two referral hospitals and healthcare utilization data-we estimated the incidences of acute Q fever and SFGR in Moshi, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014. Cases were defined as fever and a four-fold or greater increase in antibody titers of acute and convalescent paired sera according to the indirect immunofluorescence assay of Coxiella burnetii phase II antigen for acute Q fever and Rickettsia conorii (2007-2008) or Rickettsia africae (2012-2014) antigens for SFGR. Healthcare utilization data were used to adjust for underascertainment of cases by sentinel surveillance. For 2007 to 2008, among 589 febrile participants, 16 (4.7%) of 344 and 27 (8.8%) of 307 participants with paired serology had Q fever and SFGR, respectively. Adjusted annual incidence estimates of Q fever and SFGR were 80 (uncertainty range, 20-454) and 147 (uncertainty range, 52-645) per 100,000 persons, respectively. For 2012 to 2014, among 1,114 febrile participants, 52 (8.1%) and 57 (8.9%) of 641 participants with paired serology had Q fever and SFGR, respectively. Adjusted annual incidence estimates of Q fever and SFGR were 56 (uncertainty range, 24-163) and 75 (uncertainty range, 34-176) per 100,000 persons, respectively. We found substantial incidences of acute Q fever and SFGR in northern Tanzania during both study periods. To our knowledge, these are the first incidence estimates of either disease in sub-Saharan Africa. Our findings suggest that control measures for these infections warrant consideration.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolDelivery of Health CareFemaleHumansIncidenceInfantMaleMiddle AgedQ FeverSpotted Fever Group RickettsiosisTanzania

Identifiers

PMID34929672
PMCPMC8832940
OpenAlexW4200003589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.